ResearcherJiaxing UniversityActive in the last 2 years

Shuai Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8326-0056; OpenAlex author ID A5100396685. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Single-cell and multi-omics analysis identifies TRIM9 as a key ubiquitination regulator in pancreatic cancer. Last author DOI 10.3389/fimmu.2025.1631708 ↗
LINC00261 elevation inhibits angiogenesis and cell cycle progression of pancreatic cancer cells by upregulating SCP2 via targeting FOXP3. Last author DOI 10.1111/jcmm.16930 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Liang Chen · 1 shared paper, 2025 · strength 0.33
- Paper Single-cell and multi-omics analysis identifies TRIM9 as a key ubiquitination regulator in pancreatic cancer. DOI 10.3389/fimmu.2025.1631708 ↗
Xuanzeng Pei · 1 shared paper, 2021 · strength 0.17
- Paper LINC00261 elevation inhibits angiogenesis and cell cycle progression of pancreatic cancer cells by upregulating SCP2 vi… DOI 10.1111/jcmm.16930 ↗
Jun Zou · 1 shared paper, 2021 · strength 0.17
- Paper LINC00261 elevation inhibits angiogenesis and cell cycle progression of pancreatic cancer cells by upregulating SCP2 vi… DOI 10.1111/jcmm.16930 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.